Cancer doesn’t sleep, and neither do we

Thank you so much to our Tour de Cure community for supporting and sharing our previous episodes. We are so interested to be able to keep in close contact with what our researchers are working on, and being reminded of Tour de Cure’s first priority, which is cancer research, prevention and support for those on a cancer journey.

Our seventh webinar in the series 'Cancer doesn't sleep and neither do we' saw Matt Clarke chatting with the Prostate Cancer Foundation of Australia (PCFA); Sally Sara, Director of the PCFA Nursing Program and CEO of PCFA, Jeff Dun AO.
Sally gave us an update on the Prostate Cancer Specialist nurses program run Australia-wide. Jeff also gave us an update on a TdC funded Prostate Cancer project, Thera-P.

Check it out here!

Check out our previous Webinars here

Our first webinar was hosted by Paul Mirabelle, Chair of the Research, Support and Prevention Committee and TdC Board member with Children’s Cancer Institute (CCI) panellists Prof Michelle Haber AM and Prof Richard Lock.

During this interview, Paul finds out what the Institute is doing in the face of the COVID-19 crisis, and how their teams continue to work on translational research to improve outcomes for cancer patients undergoing treatment.

Our second webinar Matt Clarke spoke with Kendra Overall and Tegan Davies from Camp Quality. We chatted about how families are coping with COVID-19 and what Camp Quality is doing to improve this period for them, and the launch of a new digital platform, the Happiness Hub and the #positivitypandemic.

Check out our third lunchtime webinar from the series ‘Cancer doesn’t sleep, and neither do we'.

Paul Mirabelle was joined by Professor Matthias Ernst and Dr Jessica Duarte from the Olivia Newton John Cancer Research Institute. Both these researchers have had their research work supported by Tour de Cure, in gastrointestinal cancers and immunotherapy respectively.
They spoke about facing adversity, the role of the Olivia Newton John Cancer Research Institute with Cancer Research in Australia and globally, ONJ’s well known patron and Matthias’ rider experience during 2 Signature Tours.

In our fourth webinar, Paul Mirabelle chatted with Associate Professor Michael Michael from Flinders University in South Australia, who has recently been appointed Lead of the Cancer Research Program in the new Flinders Health and Medical Research Institute and has received two Tour de Cure Grants in the past.
Paul and Michael covered off the importance of philanthropic fundraising, how this can leverage further government support, how Flinders is uniquely placed within the cancer research world, and the significance of supporting early career researchers.

In our fifth webinar our MD, Matt Clarke, chatted with Dr Matthew Dun from the University of Newcastle/Hunter Medical Research Institute about his daughter Josie’s fight with DIPG.

We’ll also hear an update on Matt’s grant supported by Tour de Cure, ‘Blueprint for a Cure - Mapping the proteogenomic architecture of DIPG’ and his continued research in both DIPG and leukemia.

More information on Dr Matt Dun here

In our sixth webinar we chatted with Dr Laura Franshaw, a fast-rising researcher from Children’s Cancer Institute (CCIA) in Sydney. She specialises in children’s brain cancers and currently focuses on DIPG, an aggressive and fatal cancer that impacts about 20 Australian children each year. Laura has received 2 grants from TdC, so we discussed the progress in both, as well as being a female researcher in 2020, work/life balance and her exciting news!